Rapid qualitative analysis vs the 'traditional approach': early findings and ...NIHR CLAHRC West Midlands
Dr Beck Taylor of Theme 1, Maternity and Child Health, presented her latest project, comparing a rapid approach to synthesising evidence from qualitative research to traditional research methods, presented at CLAHRC WM Programme Steering Committee meeting, 22nd October 2015
Rapid qualitative analysis vs the 'traditional approach': early findings and ...NIHR CLAHRC West Midlands
Dr Beck Taylor of Theme 1, Maternity and Child Health, presented her latest project, comparing a rapid approach to synthesising evidence from qualitative research to traditional research methods, presented at CLAHRC WM Programme Steering Committee meeting, 22nd October 2015
What happens to your grant once it gets to a study section?
In this presentation, Dr. Paul Martin leverages his experience as a seasoned National Institutes of Health grant reviewer, including his tenure as Chair of the Cancer Immunopathology and Immunotherapy Study Section, to provide insight into the workings of NIH study sections.
Learn how to:
- Identify the fundamentals of grant review, including an overview of study sections and grant scoring;
- Determine differences between "impact" and "significance";
- Recognize effective strategies in writing and how to avoid frequent mistakes.
Please join CPSI as we conclude our Human Factors webinar series with our final presentation Collaborative "Spaces" and Health Information Technology Design
Ruth Thorlby: capturing patient and staff thoughts in evaluation Nuffield Trust
Ruth Thorlby, Acting Director of Policy at the Nuffield Trust, presents reflections on the challenges of capturing patient and staff thoughts in evaluations
Introduction: what is the SW-CRT?: Defining features, common variations, and some salient examples
Dr Karla Hemming
Society for Clinical Trials Conference; Arlington, Virginia
May 17th 2015
This presentation was part of the workshop organised by Karla Hemming: Research and reporting methods for the stepped wedge cluster randomised controlled trial
Modelling causal pathways in health services: a critique - Jeffrey Braithwaite.NIHR CLAHRC West Midlands
Prof Jeffrey Braithwaite's critique of the two-part talk from Richard Lilford and Sam Watson on modelling causal pathways in health services for the CLAHRC West Midlands Scientific Advisory Group meeting, 9th June 2015, Birmingham, UK
Presented as part of the Capacity Building in Policy Briefs Development Workshop conducted by Research Chair for Evidence-Based Health Care and Knowledge Translation
In collaboration with World Health Organization, Regional Office for the Eastern Mediterranean in King Saud University 2019.
What happens to your grant once it gets to a study section?
In this presentation, Dr. Paul Martin leverages his experience as a seasoned National Institutes of Health grant reviewer, including his tenure as Chair of the Cancer Immunopathology and Immunotherapy Study Section, to provide insight into the workings of NIH study sections.
Learn how to:
- Identify the fundamentals of grant review, including an overview of study sections and grant scoring;
- Determine differences between "impact" and "significance";
- Recognize effective strategies in writing and how to avoid frequent mistakes.
Please join CPSI as we conclude our Human Factors webinar series with our final presentation Collaborative "Spaces" and Health Information Technology Design
Ruth Thorlby: capturing patient and staff thoughts in evaluation Nuffield Trust
Ruth Thorlby, Acting Director of Policy at the Nuffield Trust, presents reflections on the challenges of capturing patient and staff thoughts in evaluations
Introduction: what is the SW-CRT?: Defining features, common variations, and some salient examples
Dr Karla Hemming
Society for Clinical Trials Conference; Arlington, Virginia
May 17th 2015
This presentation was part of the workshop organised by Karla Hemming: Research and reporting methods for the stepped wedge cluster randomised controlled trial
Modelling causal pathways in health services: a critique - Jeffrey Braithwaite.NIHR CLAHRC West Midlands
Prof Jeffrey Braithwaite's critique of the two-part talk from Richard Lilford and Sam Watson on modelling causal pathways in health services for the CLAHRC West Midlands Scientific Advisory Group meeting, 9th June 2015, Birmingham, UK
Presented as part of the Capacity Building in Policy Briefs Development Workshop conducted by Research Chair for Evidence-Based Health Care and Knowledge Translation
In collaboration with World Health Organization, Regional Office for the Eastern Mediterranean in King Saud University 2019.
How to Craft the "Significance” & "Innovation" - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
At the end of this presentation you will be able to:
Define evidence-based practice
Describe process & outline steps of EBP
Understand PICO elements & search strategy
Identify resources to support EBP
The focus of this presentation is nursing practice, although it is still of value to physicians and other health care professionals.
Alliance for CME 2009 Presentation, Wake me Up Before it’s Over:Bringing out...Wendy999
2009 ACME Presentation, co-presented with Marissa Seligman, that tackles strategies to bring innovation to live continuing medical education activities.
From the event "Specimen Science: Ethics and Policy Implications," held at Harvard Law School on November 16, 2015.
This event was a collaboration between The Center for Child Health and Policy at Case Western Reserve University and University Hospitals Rainbow Babies & Children’s Hospital; the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School; the Multi-Regional Clinical Trials Center of Harvard and Brigham and Women's Hospital; and Harvard Catalyst | The Harvard Clinical and Translational Science Center. It was supported by funding from the National Human Genome Research Institute and the Oswald DeN. Cammann Fund at Harvard University.
For more information, visit our website at http://petrieflom.law.harvard.edu/events/details/specimen-science-ethics-and-policy
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
5. Key points
• Is the activity a systematic
investigation designed to
develop or contribute to
generalizable knowledge?
• Does the research involve
obtaining information about
living individuals?
• Does the research involve
intervention or interaction with
the individuals?
• Is the information individually
identifiable?
6. Some additional considerations
• Is the work research-funded?
• If yes, then rules related to the
funding may apply
• But it may still depend
• If no, it may still depend
• Are there any legal agreements
specifying that activities may
only be used for quality
improvement?
• If yes, then it probably is QI
• But it may still depend
7. Important considerations
• Quality improvement
• Evidence: sufficient to support
practice change?
• Clinical staff: are local staff who are
already employed the people doing
the work?
• Methods: are they flexible and
adaptable?
• Population: current patients?
• Consent: is current clinical consent
sufficient?
• Benefits: current patients now?
• Risk: greater than current standard of
care?
• Research
• Evidence: discovery of new evidence,
or implementation of existing?
• Clinical staff: research staff?
• Methods: are they focused on
internal validity?
• Population: selected sample based on
strict inclusion/exclusion criteria?
• Consent: is specific research consent
required?
• Benefits: future patients?
• Risk: greater than current standard of
care?
9. A few more considerations
Considering science– issues around theory use, development, and testing
10. Utility of theory
• We use theory all the time
• Mostly without being explicit
• Explicit theory is more useful than implicit theory
• Why do you think something will work?
• Think about causal logic
12. Implicit theory
• Designed for someone sitting at
their desk
• Need time to work through each line
of the report
• Cognitive burden is an important
consideration
• Requires understanding of the
elements of each report
• Comprehension requires detailed
knowledge of business
• Confidence that the data come from
reliable sources
• Report assumes that the recipient
understands and trusts the data
sources
• Designed for someone busy doing
clinical work
• Should be assimilable at a glance
• Cognitive burden varies by the amount
of time available
• Simple elements
• Draws the eye to important
information
• Description of data sources allows the
person to investigate if they want
to/have data access
• Describing the source gives contextual
information to the recipient
13. Overarching theory of feedback
• Underlying theoretical proposition:
• If people know their performance is not “as good as” the performance of similar other
people, they will act to improve it Individuals respond to knowledge of performance
• Their response depends on a number of factors
• Understanding the size of the gap
• Understanding trends over time
• Comparing their performance to others
• Knowing the source of the information in the report
• Cognitive ability to process the information
• Time
• Energy
• Attention
• Perception of their environment and social context– how is performance perceived as poor treated?
• Who the report comes from
• Graphic display vs. (or in addition to) text
15. Building the science
• Consider causal mechanisms
• What is the mechanism by which we get the responses we get?
• What mediates the expected mechanisms?
• How can we increase the reliability and replicability of the implementation interventions
we use?
• What are the important features of context?
• Major difference between QI and implementation science
• QI is embedded in context, rarely studies it
• IS attempts to study the effect of context
• Although we are still unclear about what we mean
16. A few comments on the state of the science
of implementation
• Current efforts to engage and articulate theory
• Lewis et al.– “theory fragments” to link strategies with mechanisms
• Davidoff et al.– call for articulating theory explicitly
• Note: a basic scientist would never conduct an experiment without explicitly stating their
hypotheses– which arise from the underlying theory
• Gabbay and LeMay– building theory from observation
• Theory can be somewhat surprising when it comes from deep knowledge and practice
observation
• Why do we use theory so little?
• Core underlying disciplines seem atheoretical
• Medicine, health services research
• Operate extensively with very implicit, mostly unstated, theory
• An obsession with whether something works
• Very little attention to why it does or does not work
17. Pulling this all together
• Not everything has to be about science
• We need practitioners of implementation informed by science
• Tools and approaches within quality improvement are amenable to adaptation and
use of tools developed through implementation science
• But we need better science to keep moving forward on discovery
• We are currently pretty “stuck” on science in this field
• Lots of opportunities and frontiers
• Need committed, consistent scientists who develop and attend to theory
• Even when the labs are complex and difficult to build and maintain
• Even when the push is to “just do it”
• We’re not actually running a race
• We’re trying to understand the complex relationships between runners and the conditions in which
they run races